Clinical Trial

Effects of Analgesia Nociception Index (ANI)-Guided Analgesia on Postoperative Bowel Function.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2024 (before its estimated October 14, 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigators will examaine the effects of Analgesia Nociception Index (ANI)-guided analgesia on postoperative bowel function recovery in laparoscopic colorectal surgery. This is a prospective randomized-controlled study. Investigators will randomly divide the patients into two groups. In ANI group, remifentanil infusion rate during anesthesia will be adjusted according to ANI monitoring. In Control group, remifentanil infusion rate during anesthesia will be adjusted according to the conventional method of blood pressure and heart rate monitroing. And Investigators will evalualte the bowel function recovery in both groups after surgery, and compare between the two groups.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-11-04; most recent amendment 2024-09-02.
Status change: Not Yet Recruiting → Recruiting 2021-12-02
Trial Details
NCT Number NCT05122078
Lead Sponsor Gangnam Severance Hospital
Conditions Postoperative Bowel Function Recovery
Enrollment 80 participants
Start Date 2021-11-29
Primary Completion 2025-10-14 (estimated)
Study Completion 2025-10-14 (estimated)
Updated on ClinicalTrials.gov 2024-09-05